They found that people taking GLP-1s were less likely to have anemia, blood clots in veins, low levels of white blood cells called neutrophils, low blood platelet count, sepsis, nausea and vomiting, fatigue, cardiomyopathy, and neuropathy after chemotherapy
Characterized by insulin resistance, gradual progressive loss of insulin secretion by -cells, and being heavily driven by being overweight or obese [98], T2DM leads to hyperglycemia, excessive urine production, increased risk of cardiovascular disease, and changes in energy metabolism [106]
In clinical trials, injection sites include the abdomen and thigh
This evolutionary mechanism essentially tells your body to travel to a different food source, and by the time your appetite returns, you'll be somewhere else
Pan H-C, Chen J-Y, Chen H-Y, Yeh F-Y, Sun C-Y, Huang TT-M, et al
He notes that this approach can be especially helpful for patients who have had difficulty with other weight loss medications or who worry about digestive side effects
